# Eledon Pharmaceuticals, Inc.: Form 8-K, filed Aug 14, 2025

- Company: [Eledon Pharmaceuticals, Inc.](/companies/eldn.md) (CIK 1404281)
- Form: 8-K
- Filed: 2025-08-14
- Accepted by EDGAR: Aug 14, 2025, 16:30 ET
- Period: 2025-08-11
- Accession: 0001193125-25-180820
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1404281/000119312525180820/eldn-20250811.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1404281/000119312525180820/

## Items reported

- Item 2.02: Results of operations
- Item 4.02: Non-reliance on financial statements
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1404281/000119312525180820/eldn-20250811.htm

Filed Aug 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-180820. Last ingested by Listed: Nov 13, 2026, 16:16 ET. No prices; not investment advice.
